FDA Inspection 1244425 — Fagron Compounding Services

Fagron Compounding Services — FEI 3012104093

The FDA completed an inspection of Fagron Compounding Services on June 28, 2024 in Wichita, KS. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
June 28, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Wichita, KS (United States)